RA CAPITAL MANAGEMENT, L.P.
Companies Traded
5
Total Buys
10
$119.24M
Total Sells
3
$58.38M
Net Position
+$60.87M
Net Buyer
Company Activity
| Company | Role | Buys | Sells | Holdings | Last Activity |
|---|---|---|---|---|---|
| SGP SpyGlass Pharma, Inc. | OTHER | 2 $59.04M | 0 $0 | 5,966,439 $95.46M | Feb 9, 2026 |
| FULC Fulcrum Therapeutics, Inc. | OTHER | 0 $0 | 3 $58.38M | 6,145,682 $87.76M | Dec 8, 2025 |
| WVE Wave Life Sciences Ltd. | OTHER | 4 $54.62M | 0 $0 | 26,975,505 $175.34M | Mar 30, 2026 |
| BCAX Bicara Therapeutics Inc. | OTHER | 1 $4.80M | 0 $0 | 4,603,418 $73.65M | Feb 26, 2026 |
| CLYM Climb Bio, Inc. | OTHER | 3 $780K | 0 $0 | 3,403,429 $11.91M | Jan 5, 2026 |
Recent Transactions
Wave Life Sciences Ltd.
Shares
971,091
Price
$7
Total Value
$6.31M
Date
Mar 30, 2026
Wave Life Sciences Ltd.
Shares
2,495,623
Price
$6
Total Value
$16.05M
Date
Mar 27, 2026
Wave Life Sciences Ltd.
Shares
4,954,558
Price
$6
Total Value
$30.02M
Date
Mar 26, 2026
Wave Life Sciences Ltd.
Shares
351,224
Price
$6
Total Value
$2.24M
Date
Mar 26, 2026
Bicara Therapeutics Inc.
Shares
300,000
Price
$16
Total Value
$4.80M
Date
Feb 26, 2026
SpyGlass Pharma, Inc.
Shares
3,441,966
Price
$16
Total Value
$55.07M
Date
Feb 9, 2026
SpyGlass Pharma, Inc.
Shares
248,034
Price
$16
Total Value
$3.97M
Date
Feb 9, 2026
Climb Bio, Inc.
Shares
101,462
Price
$3
Total Value
$290K
Date
Dec 12, 2025
Climb Bio, Inc.
Shares
213,099
Price
$2
Total Value
$465K
Date
Dec 11, 2025
Fulcrum Therapeutics, Inc.
Shares
2,706,397
Price
$14
Total Value
$38.65M
Date
Dec 8, 2025
Fulcrum Therapeutics, Inc.
Shares
1,377,020
Price
$13
Total Value
$18.36M
Date
Dec 8, 2025
Fulcrum Therapeutics, Inc.
Shares
91,722
Price
$15
Total Value
$1.37M
Date
Dec 8, 2025
Trading Timeline
First Transaction
Dec 8, 2025
Latest Transaction
Mar 30, 2026